期刊文献+

进展性卒中的临床探讨 被引量:13

Study of the stroke in progression
下载PDF
导出
摘要 目的深入探讨进展性卒中的临床特点、病因和意义。方法将发病24h内入院治疗的306例脑梗死患者进行随机分组,观察进展性卒中患者的临床表现,并将其血压、血糖、血脂、纤维蛋白原、梗死部位、脑彩超、颈部彩超结果与非进展组进行比较。结果进展性卒中神经功能缺失症状加重以24h内最常见,高血压和糖尿病是进展性卒中的重要病因,纤维蛋白原增高,梗死部位及血管狭窄程度是进展性卒中发生的重要原因。结论针对可引起展性卒中的危险因素进行积极干预可有效抑制其发生。 Objective To explore the etiology,clinical manifestations,diagnosis,as well as the treatment program and enhance the recognition to stroke in progression.Methods We performed retrospective analysis on the original data of the 306 cerebral infarction patients who presented within 24 hours of onset.A total of 153 patients were diagnosed as stroke in progression (SIP)and non-progression stroke group (NPS) according to their decrease scores in Scandinavian stroke scale (SSS)from baseline to the 1-week evaluation.The SIP and NPS stroke patients were compared in terms of their background characteristics,blood pressure,blood glucose,cholesterol,fibrinogen,cranial CT and TCD.Results The overall incidence of SIP was 34.64%.Hypertension and hyperglycemia differed significantly between SIP group and NPS group.Higher FIB and the infarct region were important factors of worsening.The infarct in watershed,besides body of lateral ventricle and large volume infarction were more common in SIP.Stenosis,especially the medium or severe stenosis of the MCA,extracranial section of the internal carotid artery was an important risk factor for SIP.Conclusion We should adopt attention to the cerebral infarction patients who presented within 24 hours of onset probably.Cranial CT and TCD examination were essential.We should adopt effective method to prevent and cure the risk factors leading to SIP.
出处 《中国实用神经疾病杂志》 2010年第10期14-16,共3页 Chinese Journal of Practical Nervous Diseases
关键词 进展性卒中 临床特点 病因 Stroke in progression Clinical manifestation Etiology
  • 相关文献

参考文献8

二级参考文献16

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 2中华医学会神经病学分会.急性缺血性脑卒中患者处理建议(1998)[J].中华神经科杂志,1998,10(30):305-306.
  • 3Carberg B, Asplund K, Hagge E. Factors influencing admission blood pressure levels in acute stroke. Stroke, 1991, 22(4):527
  • 4Philips SJ. Pathophysiology and management of hypertension in acute ischemic stroke. Hypertension, 1994, 23 ( 1 ): 131
  • 5Ceriello A, Falleti E, Bortolotti N, et al. Increased circulating intercellular adhesion molecule-lexpression in cultured human vascular endothelial cells. Cells J clin Invest, 1994, 98:885
  • 6Mcleod Ds, Lefer DJ, Merges C, et al. Enhanced expression of ihtercellular adhesion molecule-land P-selectin in the diabetic human retina and chroid. AM J Pathol, 1995, 147:642
  • 7Linn T, Stmate C, Federlin K, et al. Intercellular adhesion molecule-1, expression in the islets of nonobese diabetes and lowdosestretozocin-treated mouse. Histochemistry, 1994, 102:317
  • 8Herold K, Vezys V, Gage A, et al. Prevention of autoimmune diabetes by treatment with anti-LFA-1 and anti-ICAM-1 monoclonal antibody. Cell Immunoi, 1994, 157:489
  • 9Matsui H, Suzuki M, Tsukuda R, ET al. expression of ICAM-1 on glumeruli isassociated with pyogression of diabetic nephropathy in a genetically obese diabetic rats wister fatty. Diabetes Res clin pract,1996, 32(1-2):1
  • 10Cautier MD. Stroke-in-progression. Stroke, 1985,16(4): 1876

共引文献351

同被引文献167

引证文献13

二级引证文献69

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部